Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
PHASE2
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection
NA
To restore immunologic function and virus-free state in HIV-infected patien...
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
PHASE3
RATIONALE: Giving chemotherapy drugs, such as melphalan, work in different ...
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
PHASE2
RATIONALE: Giving chemotherapy drugs, such as fludarabine and melphalan, be...
Status
Unknown
Location
Herbert Irving Comprehensive Cancer Center at Columbia University
Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma
PHASE2
This phase II trial studies the side-effects and anti-cancer effects of giv...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium